[
Abreu IM, Lau E, de Sousa Pinto B, Carvalho D. Subclinical hypothyroidism: to treat or not to treat, that is the question! A systematic review with meta-analysis on lipid profile. Endocr Connect 6, 188–199, 2017.10.1530/EC-17-0028542891128249936
]Search in Google Scholar
[
Adler SM, Wartofsky L. The nonthyroidal illness syndrome. Endocrinol Metab Clin North Am 36, 657–672, 2007.10.1016/j.ecl.2007.04.00717673123
]Search in Google Scholar
[
Andersen MN, Olsen AM, Madsen JC, Faber J, Torp-Pedersen C, Gislason GH, Selmer C. Levothyroxine substitution in patients with subclinical hypothyroidism and the risk of myocardial infarction and mortality. PloS one 10, e0129793, 2015.10.1371/journal.pone.0129793446640026069971
]Search in Google Scholar
[
Andersen MN, Olsen AS, Madsen JC, Kristensen SL, Faber J, Torp-Pedersen C, Gislason GH, Selmer C. Long-term outcome in levothyroxine treated patients with subclinical hypothyroidism and concomitant heart disease. J Clin Endocr Metab 101, 4170–4177, 2016.10.1210/jc.2016-222627571183
]Search in Google Scholar
[
Bano A, Dhana K, Chaker L, Kavousi M, Ikram MA, Mattace-Raso FUS, Peeters RP, Franco OH. Association of thyroid function with life expectancy with and without cardiovascular disease: the Rotterdam study. JAMA Intern Med 177, 1650–1657. 2017.10.1001/jamainternmed.2017.4836571026628975207
]Search in Google Scholar
[
Bhatnagar AD. Study to find out incidence of cardiac manifestation in thyroid disorder (hypo and hyper both). Sch J App Med Sci 6, 2180–2184, 2018.
]Search in Google Scholar
[
Bartalena L, Bogazzi F, Chiovato L, Hubalewska-Dydejczyk A, Links TP, Vanderpump M. 2018 European Thyroid Association (ETA) guidelines for the management of amiodarone-associated thyroid dysfunction. Eur Thyroid J 7, 55–66, 2018.
]Search in Google Scholar
[
Basaria S, Cooper DS. Amiodarone and the thyroid. Am J Med 118, 706–714, 2005.10.1016/j.amjmed.2004.11.02815989900
]Search in Google Scholar
[
Baumgartner C, Blum MR, Rodondi N. Subclinical hypothyroidism: summary of evidence in 2014. Swiss Med Wkly 144, w14058, 2014.10.4414/smw.2014.1405825536449
]Search in Google Scholar
[
Behera BK, Satpathy A, Samal K. Cardiovascular changes in newly detected hypothyroid patients in Eastern India. Int J Res Med Sci 5, 4302–4306, 2017.10.18203/2320-6012.ijrms20174171
]Search in Google Scholar
[
Biondi B. Heart failure and thyroid dysfunction. Eur J Endocrinol 167, 609–618, 2012.10.1530/EJE-12-062722956554
]Search in Google Scholar
[
Biondi B, Bartalena L, Cooper DS, Hegedus L, Laurberg P, Kahaly GJ. The 2015 European Thyroid Association guidelines on diagnosis and treatment of endogenous subclinical hyperthyroidism. Eur Thyroid J 4, 149–163, 2015.10.1159/000438750463751326558232
]Search in Google Scholar
[
Bozkurt B, Colvin M, Cook J, Cooper LT, Deswal A, Fonarow GC, Francis GS, Lenihan D, et al. Current diagnostic and treatment strategies for specific dilated cardiomyopathies: a scientific statement from the American Heart Association. Circulation 134, e579–e646, 2016.10.1161/CIR.000000000000045527832612
]Search in Google Scholar
[
Cai Y, Ren Y, Shi J. Blood pressure levels in patients with subclinical thyroid dysfunction: a meta-analysis of cross-sectional data. Hypertens Res 34, 1098–1105, 2011.10.1038/hr.2011.9121796125
]Search in Google Scholar
[
Cappola AR, Fried LP, Arnold AM, Danese MD, Kuller LH, Burke GL, Tracy RP, Ladenson PW. Thyroid status, cardiovascular risk, and mortality in older adults. JAMA 295, 1033–1041, 2006.10.1001/jama.295.9.1033138782216507804
]Search in Google Scholar
[
Chaker L, Baumgartner C, Ikram MA, Dehghan A, Medici M, Visser WE, Hofman A, Rodondi N, Peeters RP, Franco OH. Subclinical thyroid dysfunction and the risk of stroke: a systematic review and meta-analysis. Eur J Epidemiol 29, 791–800, 2014.10.1007/s10654-014-9946-825179793
]Search in Google Scholar
[
Chakera AJ, Pearce SH, Vaidya B. Treatment for primary hypothyroidism: current approaches and future possibilities. Drug Des Devel Ther 6, 1–11, 2012.10.2147/DDDT.S12894326751722291465
]Search in Google Scholar
[
Chang CY, Chien YJ, Lin PC, Chen CS, Wu MY. Non-thyroidal illness syndrome and hypothyroidism in ischemic heart disease population: Systematic review and meta-analysis. J Clin Endocr Metab 105, dgaa310, 2020.10.1210/clinem/dgaa31032459357
]Search in Google Scholar
[
Charles L, Triscott J, Dobbs B. Secondary hypertension: discovering the underlying cause. Am Fam Physician 96, 453–461, 2017.
]Search in Google Scholar
[
Chaudhary N, Duggal AK, Makhija P, Puri V, Khwaja GA. Statin-induced bilateral foot drop in a case of hypothyroidism. Ann Indian Acad Neurol 18, 331–334, 2015.10.4103/0972-2327.157251456447026425013
]Search in Google Scholar
[
Chen YF, Kobayashi S, Chen J, Redetzke RA, Said S, Liang Q, Gerdes AM. Short term triiodo-L-thyronine treatment inhibits cardiac myocyte apoptosis in border area after myocardial infarction in rats. J Mol Cell Cardiol 44, 180–187, 2008.10.1016/j.yjmcc.2007.09.009223581417964598
]Search in Google Scholar
[
Collet TH, Gussekloo J, Bauer DC, den Elzen WP, Cappola AR, Balmer P, Iervasi G, Asvold BO, et al. Subclinical hyperthyroidism and the risk of coronary heart disease and mortality. Arch Intern Med. 172, 799–809, 2012.10.1001/archinternmed.2012.402387247822529182
]Search in Google Scholar
[
Dahl P, Danzi S, Klein I. Thyrotoxic cardiac disease. Curr Heart Fail Rep 5, 170–176, 2008.10.1007/s11897-008-0026-918752767
]Search in Google Scholar
[
Davis PJ, Davis FB, Mousa SA. Thyroid hormone-induced angiogenesis. Curr Cardiol Rev 5, 12–16, 2009.10.2174/157340309787048158280328220066142
]Search in Google Scholar
[
Dey A, Kanneganti V, Das D. A study of the cardiac risk factors emerging out of subclinical hypothyroidism. J Family Med Prim Care 8, 2439–2444, 2019.10.4103/jfmpc.jfmpc_348_19669144831463273
]Search in Google Scholar
[
Dorr M, Ruppert Jr, Robinson DM, Kors JA, Felix SB, Volzke H. The relation of thyroid function and ventricular repolarization: decreased serum thyrotropin levels are associated with short rate-adjusted QT intervals. J Clin Endocr Metab 91, 4938–4942, 2004.10.1210/jc.2006-101716968798
]Search in Google Scholar
[
Dorr M, Robinson DM, Wallaschofski H, Schwahn C, John U, Felix SB, Volzke H. Low serum thyrotropin is associated with high plasma fibrinogen. J Clin Endocr Metab 91, 530–534, 2006.10.1210/jc.2005-178616303831
]Search in Google Scholar
[
Duntas LH, Brenta G. A renewed focus on the association between thyroid hormones and lipid metabolism. Front Endocrinol 9, 511, 2018.10.3389/fendo.2018.00511612960630233497
]Search in Google Scholar
[
Erem C, Kavgaci H, Ersoz HO, Hacihasanoglu A, Ukinc K, Karti SS, Deger O, Telatari M. Blood coagulation and fibrinolytic activity in hypothyroidism. Int J Clin Pract 57, 78–81, 2003.
]Search in Google Scholar
[
Erem C. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity. Clin Endocrinol (Oxf) 64, 323–329, 2006.10.1111/j.1365-2265.2006.02464.x16487444
]Search in Google Scholar
[
Ertek S, Cicero AF. Hyperthyroidism and cardiovascular complications: a narrative review on the basis of pathophysiology. Arch Med Sci 9, 944, 2013.10.5114/aoms.2013.38685383283624273583
]Search in Google Scholar
[
Institute for Health Metrics and Evaluation. GBD Compare 2010. http://vizhub.healthdata.org/gbd-compare/. Accessed April 30, 2014.
]Search in Google Scholar
[
Forini F, Lionetti V, Ardehali H, Pucci A, Cecchetti F, Ghanefar M, Nicolini G, Ichikawa Y, Nannipieri M, Recchia FA, Iervasi G. Early long‐term L‐T3 replacement rescues mitochondria and prevents ischemic cardiac remodelling in rats. J Cell Mol Med 15, 514–524, 2011.10.1111/j.1582-4934.2010.01014.x392237320100314
]Search in Google Scholar
[
Franchini M, Lippi G, Targher G. Hyperthyroidism and venous thrombosis: a casual or causal association? A systematic literature review. Clin Appl Thromb-Hem 17, 387–392, 2011.10.1177/107602961036452120308227
]Search in Google Scholar
[
Fukuyama K, Ichiki T, Takeda K, Tokunou T, Iino N, Masuda S, Ishibashi M, Egashira K, Shimokawa H, Hirano K, Kanaide H, Takeshita A. Downregulation of vascular angiotensin II type 1 receptor by thyroid hormone. Hypertension 41, 598–603, 2003.10.1161/01.HYP.0000056524.35294.8012623965
]Search in Google Scholar
[
Fuster V, Ryden LE, Asinger RW, Cannom DS, Crijns HJ, Frye RL, et al. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary. a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation) Developed in collaboration with the North American Society of Pacing and Electrophysiology. J Am Coll Cardiol 38, 1231–1265, 2001.
]Search in Google Scholar
[
Fuster V, Ryden LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, Halperin JL, Le Heuzey JY, et al. ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation-Executive Summary. A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines. (Writing Committee to Revise the 2001 Guidelines for the Management of Patients with Atrial Fibrillation). Eur Heart J 27, 1979–2030, 2006.10.1093/europace/eum142
]Search in Google Scholar
[
Garber JR, Cobin RH, Gharib H, Hennessey JV, Klein I, Mechanick JI, Pessah-Pollack R, Singer PA, Woeber KA; American Association Of Clinical Endocrinologists And American Thyroid Association Taskforce On Hypothyroidism In Adults. Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association. Thyroid 22, 1200–1235, 2012.10.1089/thy.2012.020522954017
]Search in Google Scholar
[
Gencer B, Collet TH, Virgini V, Bauer DC, Gussekloo J, Cappola AR, Nanchen D, den Elzen WP, Balmer P, Luben RN, Iacoviello M, Triggiani V, Cornuz J, Newman AB, Khaw KT, Jukema JW, Westendorp RG, Vittinghoff E, Aujesky D, Rodondi N; Thyroid Studies Collaboration. Subclinical thyroid dysfunction and the risk of heart failure events: an individual participant data analysis from 6 prospective cohorts. Circulation 126, 1040–1049, 2012.10.1161/CIRCULATIONAHA.112.096024388457622821943
]Search in Google Scholar
[
Holmager P, Schmidt U, Mark P, Andersen U, Dominguez H, Raymond I, Zerahn B, Nygaard B, Kistorp C, Faber J. Long‐term L‐triiodothyronine (T3) treatment in stable systolic heart failure patients: a randomised, double‐ blind, cross‐over, placebo‐controlled intervention study. Clin Endocrinol (Oxf) 83, 931–937, 2015.10.1111/cen.1264825359424
]Search in Google Scholar
[
Homoncik M, Gessl A, Ferlitsch A, Jilma B, Vierhapper H. Altered platelet plug formation in hyperthyroidism and hypothyroidism. J Clin Endocr Metab 92, 3006–3012, 2007.10.1210/jc.2006-264417488803
]Search in Google Scholar
[
Iervasi G, Pingitore A, Landi P, Raciti M, Ripoli A, Scarlattini M, L’Abbate A, Donato L. Low-T3 syndrome: a strong prognostic predictor of death in patients with heart disease. Circulation 107, 708–713, 2003.10.1161/01.CIR.0000048124.64204.3F12578873
]Search in Google Scholar
[
Iervasi G, Molinaro S, Landi P, Taddei MC, Galli E, Mariani F, L’Abbate A, Pingitore A. Association between increased mortality and mild thyroid dysfunction in cardiac patients. Arch Intern Med 167, 1526–1532, 2007.10.1001/archinte.167.14.152617646607
]Search in Google Scholar
[
Inciardi RM, Chandra A, Claggett B, Wijkman M, Selvin E, Kottgen A, Kucharska-Newton A, Diem S, Schultheiss U, Shah A, Solomon SD, Vardeny O, ARIC Investigators. Thyroid dysfunction and incident heart failure phenotypes among older adults: the atherosclerosis risk in communities (aric) study. Eur Heart J 41, 2020.10.1093/ehjci/ehaa946.0866
]Search in Google Scholar
[
India State-Level Disease Burden Initiative CVD Collaborators. The changing patterns of cardiovascular diseases and their risk factors in the states of India: the Global Burden of Disease Study 1990–2016. Lancet Glob Health 6, e1339–e1351, 2018.
]Search in Google Scholar
[
Jabbar A, Pingitore A, Pearce SH, Zaman A, Iervasi G, Razvi S. Thyroid hormones and cardiovascular disease. Nat Rev Cardiol 14, 39–55, 2017.10.1038/nrcardio.2016.17427811932
]Search in Google Scholar
[
Jonklaas J, Bianco AC, Bauer AJ, Burman KD, Cappola AR, Celi FS, Cooper DS, Kim BW, Peeters RP, Rosenthal MS, Sawka AM; American Thyroid Association Task Force on Thyroid Hormone Replacement. Guidelines for the treatment of hypothyroidism: prepared by the american thyroid association task force on thyroid hormone replacement. Thyroid 24, 1670–1751, 2014.10.1089/thy.2014.0028426740925266247
]Search in Google Scholar
[
Kahaly GJ, Bartalena L, Hegedus L, Leenhardt L, Poppe K, Pearce SH. 2018 European thyroid association guideline for the management of Graves’ hyperthyroidism. Eur Thyroid J 7, 167–186, 2018.
]Search in Google Scholar
[
Kandan V, Sathyamurthy P, Rajkumar M. Cardiovascular manifestations in hyperthyroidism. Int J Res Med Sci 4, 3032–3038, 2016.10.18203/2320-6012.ijrms20161999
]Search in Google Scholar
[
Kim YA, Park YJ. Prevalence and risk factors of subclinical thyroid disease. Endocrinol Metab 29, 20–29, 2014.10.3803/EnM.2014.29.1.20
]Search in Google Scholar
[
Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B, Castella M, Diener HC, et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur J Cardiothorac Surg 50, e1–e88, 2016.
]Search in Google Scholar
[
Klein I, Danzi S. Thyroid disease and the heart. Curr Prob Cardiol 41, 65–92, 2016.10.1016/j.cpcardiol.2015.04.002
]Search in Google Scholar
[
Kravets I. Hyperthyroidism: diagnosis and treatment. Am Fam Physician 93, 363–370, 2016.
]Search in Google Scholar
[
Kuchulakanti PK, Bandaru VS, Kuchulakanti A, Lakshumaiah T, Rathod M, Khare R, Sairam P, Reddy PR, Ravikanth A, Guruprakash A, Reddy RP. Association of subclinical hypothyroidism in heart failure: a study from South India. Br J Cardiol 26, 35, 2019.
]Search in Google Scholar
[
Ladenson PW. Recognition and management of cardiovascular disease related to thyroid dysfunction. Am J Med 88, 638–641, 1990.10.1016/0002-9343(90)90532-I
]Search in Google Scholar
[
Lee YS, Choi JW, Bae EJ, Park WI, Lee HJ, Oh PS. The corrected QT (QTc) prolongation in hyperthyroidism and the association of thyroid hormone with the QTc interval. Korean J Pediatr 58, 263–266, 2015.10.3345/kjp.2015.58.7.263454318626300941
]Search in Google Scholar
[
Li X, Wang Y, Guan Q, Zhao J, Gao L. The lipid‐lowering effect of levothyroxine in patients with subclinical hypothyroidism: A systematic review and meta‐analysis of randomized controlled trials. Clin Endocrinol (Oxf) 87, 1–9, 2017.10.1111/cen.1333828342184
]Search in Google Scholar
[
Liu XL, He S, Zhang SF, Wang J, Sun XF, Gong CM, Zheng SJ, Zhou JC, Xu J. Alteration of lipid profile in subclinical hypothyroidism: a meta-analysis. Med Sci Monit 20, 1432–1441, 2014.10.12659/MSM.891163414494625124461
]Search in Google Scholar
[
Lymvaios I, Mourouzis I, Cokkinos DV, Dimopoulos MA, Toumanidis ST, Pantos C. Thyroid hormone and recovery of cardiac function in patients with acute myocardial infarction: a strong association? Eur J Endocrinol 165, 107–114, 2011.10.1530/EJE-11-006221490121
]Search in Google Scholar
[
Manolis AA, Manolis TA, Melita H, Manolis AS. Subclinical thyroid dysfunction and cardiovascular consequences: An alarming wake-up call? Trends Cardiovas Med 30, 57–69, 2020.10.1016/j.tcm.2019.02.01130871865
]Search in Google Scholar
[
Marin-Garcia J, Goldenthal MJ. Mitochondrial centrality in heart failure. Heart fail rev 13, 137–150, 2008.10.1007/s10741-007-9079-118185992
]Search in Google Scholar
[
Mastropasqua M, Spagna G, Baldini V, Tedesco I, Paggi A. Hoffman’s syndrome: muscle stiffness, pseudohypertrophy and hypothyroidism. Horm Res 59, 105–108, 2003.10.1159/00006857312589116
]Search in Google Scholar
[
Meng Y, Zhao T, Zhang ZY, Zhang DK. Association between sub-clinical hypothyroidism and heart failure with preserved ejection fraction. Chin Med J (Engl) 133, 364–366, 2020.10.1097/CM9.0000000000000631700462231904733
]Search in Google Scholar
[
Mithal A, Dharmalingam M, Tewari N. Are patients with primary hypothyroidism in India receiving appropriate thyroxine replacement? An observational study. Indian J Endocr Metab 18, 83–88, 2014.10.4103/2230-8210.126582396873924701435
]Search in Google Scholar
[
Moini J, Pereira K, Samsam M. Epidemiology of Thyroid Disorders. Elsevier, 2020.10.1016/B978-0-12-818500-1.00001-3
]Search in Google Scholar
[
Moon S, Kim MJ, Yu JM, Yoo HJ, Park YJ. Subclinical hypothyroidism and the risk of cardiovascular disease and all-cause mortality: a meta-analysis of prospective cohort studies. Thyroid 28, 1101–1110, 2018.10.1089/thy.2017.041429978767
]Search in Google Scholar
[
Nanchen D, Gussekloo J, Westendorp RG, Stott DJ, Jukema JW, Trompet S, Ford I, Welsh P, Sattar N, Macfarlane PW, Mooijaart SP, Rodondi N, de Craen AJ; PROSPER Group. Subclinical thyroid dysfunction and the risk of heart failure in older persons at high cardiovascular risk. J Clin Endocr Metab 97, 852–861, 2012.Ochs N, Auer R, Bauer DC, Nanchen D, Gussekloo J, Cornuz J, Rodondi N. Meta-analysis: subclinical thyroid dysfunction and the risk for coronary heart disease and mortality. Ann Intern Med 148, 832–845, 2008.10.1210/jc.2011-197822238391
]Search in Google Scholar
[
Pantos C, Malliopoulou V, Mourouzis I, Karamanoli E, Moraitis P, Tzeis S, Paizis I, Cokkinos AD, Carageorgiou H, Varonos DD, Cokkinos DV. Thyroxine pretreatment increases basal myocardial heat-shock protein 27 expression and accelerates translocation and phosphorylation of this protein upon ischaemia. Eur J Pharmacol 478, 53–60, 2003a.10.1016/j.ejphar.2003.08.03014555185
]Search in Google Scholar
[
Pantos C, Malliopoulou V, Paizis I, Moraitis P, Mourouzis I, Tzeis S, Karamanoli E, Cokkinos DD, Carageorgiou H, Varonos D, Cokkinos DV. Thyroid hormone and cardioprotection: study of p38 MAPK and JNKs during ischaemia and at reperfusion in isolated rat heart. Mol Cell Biochem 242, 173–180, 2003b.10.1007/978-1-4757-4712-6_22
]Search in Google Scholar
[
Pasqualetti G, Tognini S, Polini A, Caraccio N, Monzani F. Is subclinical hypothyroidism a cardiovascular risk factor in the elderly? J Clin Endocr Metab 98, 2256–2266, 2013.10.1210/jc.2012-381823559085
]Search in Google Scholar
[
Pearce EN. Diagnosis and management of thyrotoxicosis. BMJ 332, 1369–1373, 2006.10.1136/bmj.332.7554.1369147672716763249
]Search in Google Scholar
[
Persani L, Brabant G, Dattani M, Bonomi M, Feldt-Rasmussen U, Fliers E, Gruters A, Maiter D, Schoenmakers N, van Trotsenburg ASP. 2018 European Thyroid Association (ETA) Guidelines on the diagnosis and management of central hypothyroidism. Eur Thyroid J 7, 225–237, 2018.
]Search in Google Scholar
[
Pingitore A, Galli E, Barison A, Iervasi A, Scarlattini M, Nucci D, L’abbate A, Mariotti R, Iervasi G. Acute effects of triiodothyronine (T3) replacement therapy in patients with chronic heart failure and low-T3 syndrome: a randomized, placebo-controlled study. J Clin Endocr Metab 93, 1351–1358, 2008.10.1210/jc.2007-221018171701
]Search in Google Scholar
[
Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ, Falk V, Gonzalez-Juanatey JR, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 18, 891–975, 2016.
]Search in Google Scholar
[
Prabhakaran D, Jeemon P, Roy A. Cardiovascular diseases in India: current epidemiology and future directions. Circulation 133, 1605–1620, 2016.10.1161/CIRCULATIONAHA.114.00872927142605
]Search in Google Scholar
[
Ravishankar MS, Harish Kumar S, Balachandra G. Cardiac Manifestations in Overt and Subclinical Hypothyroidism Subjects in a Tertiary Care Centre. J Intern Med 7, 31–35, 2018.
]Search in Google Scholar
[
Razvi S, Weaver JU, Butler TJ, Pearce SH. Levothyroxine treatment of subclinical hypothyroidism, fatal and nonfatal cardiovascular events, and mortality. Arch Intern Med 172, 811–817, 2012.10.1001/archinternmed.2012.115922529180
]Search in Google Scholar
[
Razvi S, Jabbar A, Pingitore A, Danzi S, Biondi B, Klein I, Peeters R, Zaman A, Iervasi G. Thyroid hormones and cardiovascular function and diseases. J Am Coll Cardiol 71, 1781–1796, 2018.10.1016/j.jacc.2018.02.04529673469
]Search in Google Scholar
[
Razvi S. Novel uses of thyroid hormones in cardiovascular conditions. Endocrine 66, 115–123, 2019.10.1007/s12020-019-02050-4679447431617169
]Search in Google Scholar
[
Rodondi N, Aujesky D, Vittinghoff E, Cornuz J, Bauer DC. Subclinical hypothyroidism and the risk of coronary heart disease: a meta-analysis. Am J Med 119, 541–551, 2006.10.1016/j.amjmed.2005.09.02816828622
]Search in Google Scholar
[
Rodondi N, den Elzen WP, Bauer DC, Cappola AR, Razvi S, Walsh JP, Asvold BO, Iervasi G, Imaizumi M, Collet TH, Bremner A, Maisonneuve P, Sgarbi JA, Khaw KT, Vanderpump MP, Newman AB, Cornuz J, Franklyn JA, Westendorp RG, Vittinghoff E, Gussekloo J; Thyroid Studies Collaboration. Subclinical hypothyroidism and the risk of coronary heart disease and mortality. JAMA 304, 1365–1374, 2010.10.1001/jama.2010.1361392347020858880
]Search in Google Scholar
[
Ross DS, Burch HB, Cooper DS, Greenlee MC, Laurberg P, Maia AL, Rivkees SA, Samuels M, Sosa JA, Stan MN, Walter MA. 2016 American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis. Thyroid 26, 1343–1421, 2016.
]Search in Google Scholar
[
Rush J, Danzi S, Klein I. Role of thyroid disease in the development of statin-induced myopathy. The Endocrinologist 16, 279–285, 2006.10.1097/01.ten.0000240960.40281.2b
]Search in Google Scholar
[
Saad M, Lacoste AG, Balar P, Zhang A, Vittorio TJ. The subclinical hypothyroid state might predict 30-day readmission in patients admitted with acute heart failure syndrome and reduced left ventricular ejection fraction. Ther Adv Cardiovasc Dis 14, 2020.10.1177/1753944720977742775057233336627
]Search in Google Scholar
[
Satoh T, Isozaki O, Suzuki A, Wakino S, Iburi T, Tsuboi K, Kanamoto N, Otani H, Furukawa Y, Teramukai S, Akamizu T. 2016 Guidelines for the management of thyroid storm from The Japan Thyroid Association and Japan Endocrine Society. Endocr J 63, 1025–1064, 2016.
]Search in Google Scholar
[
Sawin CT, Geller A, Wolf PA, Belanger AJ, Baker E, Bacharach P, Wilson PW, Benjamin EJ, D’Agostino RB. Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. N Engl J Med 331, 1249–1252, 1994.10.1056/NEJM1994111033119017935681
]Search in Google Scholar
[
Schenck JB, Rizvi AA, Lin T. Severe primary hypothyroidism manifesting with torsades de pointes. Am J Med Sci 331, 154–156, 2006.10.1097/00000441-200603000-0000816538077
]Search in Google Scholar
[
Shende P, Choudhari S, Kelkar M, Chafekar N. A study of cardiovascular changes in newly detected hypothyroid patients. MVP J Med Sci 4, 102–106, 2017.
]Search in Google Scholar
[
Schmidt-Ott UM, Ascheim DD. Thyroid hormone and heart failure. Curr Heart Fail Rep 3, 114–119, 2006.10.1007/s11897-006-0010-116914103
]Search in Google Scholar
[
Selmer C, Olesen JB, Hansen ML, von Kappelgaard LM, Madsen JC, Hansen PR, Pedersen OD, Faber J, Torp-Pedersen C, Gislason GH. Subclinical and overt thyroid dysfunction and risk of all-cause mortality and cardiovascular events: a large population study. J Clin Endocr Metab 99, 2372–2382, 2014.10.1210/jc.2013-418424654753
]Search in Google Scholar
[
Selvamuthukumaran S. Cardiovascular manifestations in patients with hypothyroidism in rural South India – a prospective study. Int J Contemp Med Res 5, H6–H9, 2018.10.21276/ijcmr.2018.5.8.24
]Search in Google Scholar
[
Silva J, Landsberg L. Catecholamines and the sympathoadrenal system in hypothyroidism. The thyroid: A fundamental and clinical text. New York: Lippincott Williams and Wilkins, 820–823, 2000.
]Search in Google Scholar
[
Singer DE, Albers GW, Dalen JE, Fang MC, Go AS, Halperin JL, Lip GYH, Manning WJ. Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 133, 546S–592S, 2008.10.1378/chest.08-067818574273
]Search in Google Scholar
[
Singh S, Duggal J, Molnar J, Maldonado F, Barsano CP, Arora R. Impact of subclinical thyroid disorders on coronary heart disease, cardiovascular and all-cause mortality: a meta-analysis. Int J Cardiol 125, 41–48, 2008.10.1016/j.ijcard.2007.02.02717434631
]Search in Google Scholar
[
Siu CW, Yeung CY, Lau CP, Kung AW, Tse HF. Incidence, clinical characteristics and outcome of congestive heart failure as the initial presentation in patients with primary hyperthyroidism. Heart 93, 483–487, 2007.10.1136/hrt.2006.100628186147817005710
]Search in Google Scholar
[
Squizzato A, Gerdes V, Brandjes D, Buller H, Stam J. Thyroid diseases and cerebrovascular disease. Stroke 36, 2302–2310, 2005.10.1161/01.STR.0000181772.78492.0716179578
]Search in Google Scholar
[
Stott DJ, Rodondi N, Kearney PM, Ford I, Westendorp RGJ, Mooijaart SP, Sattar N, Aubert CE, et al. Thyroid hormone therapy for older adults with subclinical hypothyroidism. N Engl J Med 376, 2534–2544, 2017.
]Search in Google Scholar
[
Sun J, Yao L, Fang Y, Yang R, Chen Y, Yang K, Tian L. Relationship between subclinical thyroid dysfunction and the risk of cardiovascular outcomes: a systematic review and meta-analysis of prospective cohort studies. Int J Endocrinol 2017, 2017.10.1155/2017/8130796561079429081800
]Search in Google Scholar
[
Toft A, Menon N. Thyroid disease and the heart. Heart 84, 455–460, 2000.10.1136/heart.84.4.455172943610995425
]Search in Google Scholar
[
Trohman RG, Sharma PS, McAninch EA, Bianco AC. Amiodarone and thyroid physiology, pathophysiology, diagnosis and management. Trends Cardiovas Med 29, 285–295, 2019.10.1016/j.tcm.2018.09.005666101630309693
]Search in Google Scholar
[
Unnikrishnan AG, Menon UV. Thyroid disorders in India: An epidemiological perspective. Indian J Endocr Metab 15, S78–S81, 2011.10.4103/2230-8210.83329316986621966658
]Search in Google Scholar
[
Vaideeswar P, Singaravel S, Gupte P. The thyroid in ischemic heart disease: An autopsy study. Indian Heart J 70, S489–S491, 2018.10.1016/j.ihj.2018.07.015630957330595314
]Search in Google Scholar
[
Vasileiou M, Gilbert J, Fishburn S, Boelaert K; Guideline Committee. Thyroid disease assessment and management: summary of NICE guidance. BMJ 368, 2020.10.1136/bmj.m4131996347
]Search in Google Scholar
[
Wang B, Liu S, Li L, Yao Q, Song R, Shao X, Li Q, Shi X, Zhang JA. Non-thyroidal illness syndrome in patients with cardiovascular diseases: a systematic review and meta-analysis. Int J Cardiol 226, 1–10, 2017.10.1016/j.ijcard.2016.10.03927776249
]Search in Google Scholar
[
Waring AC, Rodondi N, Harrison S, Kanaya AM, Simonsick EM, Miljkovic I, Satterfield S, Newman AB, Bauer DC; Health, Ageing, and Body Composition (Health ABC) Study. Thyroid function and prevalent and incident metabolic syndrome in older adults: the Health, Ageing and Body Composition Study. Clin Endocrinol (Oxf) 76, 911–918, 2012.10.1111/j.1365-2265.2011.04328.x333443022187968
]Search in Google Scholar
[
Werner SC, Ingbar SH, Braverman LE, Utiger RD. Werner & Ingbar’s the thyroid: a fundamental and clinical text. Lippincott Williams and Wilkins 549, 2005.
]Search in Google Scholar
[
Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Drazner MH, Fonarow GC, et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 128, e240–e327, 2013.
]Search in Google Scholar
[
Yang GZ, Xue FS, Liu YY, Li HX, Liu Q, Liao X. Effects of enteral different-dose levothyroxinesodium pretreatment on serum thyroid hormone levels and myocardial ischemia-reperfusion injury. Perfusion 33, 584–592, 2018.10.1177/026765911876922829722287
]Search in Google Scholar
[
Yang G, Wang Y, Ma A, Wang T. Subclinical thyroid dysfunction is associated with adverse prognosis in heart failure patients with reduced ejection fraction. BMC Cardiovasc Disor 19, 83, 2019.10.1186/s12872-019-1055-x645000530947691
]Search in Google Scholar
[
Ye Y, Xie H, Zeng Y, Zhao X, Tian Z, Zhang S. Association between subclinical hypothyroidism and blood pressure-a meta-analysis of observational studies. Endocr Pract 20, 150–158, 2014.10.4158/EP13237.OR24014003
]Search in Google Scholar
[
Yoshida K, Yoshiyama M, Omura T, Nakamura Y, Kim S, Takeuchi K, Iwao H, Yoshikawa J. Activation of mitogen-activated protein kinases in the non-ischemic myocardium of an acute myocardial infarction in rats. Jpn Circ J 65, 808–814, 2001.10.1253/jcj.65.80811548881
]Search in Google Scholar
[
Zhao T, Chen B, Zhou Y, Wang X, Zhang Y, Wang H, Shan Z. Effect of levothyroxine on the progression of carotid intima-media thickness in subclinical hypothyroidism patients: a meta-analysis. BMJ open 7, e016053, 2017.10.1136/bmjopen-2017-016053566533029061604
]Search in Google Scholar
